Riboflavin for migraine.(AN EVIDENCE-BASED APPROACH)(Clinical report): An article from: Clinical Psychiatry News

This digital document is an article from Clinical Psychiatry News, published by Thomson Gale on April 1, 2007. The length of the article is 1003 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Riboflavin for migraine.(AN EVIDENCE-BASED APPROACH)(Clinical report)
Author: Nancy Walsh
Publication:Clinical Psychiatry News (Magazine/Journal)
Date: April 1, 2007
Publisher: Thomson Gale
Volume: 35 Issue: 4 Page: 32(1)

Article Type: Clinical report

Distributed by Thomson Gale